Literature DB >> 2580994

Effects of pure interferons on Epstein-Barr virus infection in vitro.

J P Andersson, U G Andersson, I T Ernberg, S F Britton, M DeLey.   

Abstract

Pure human gamma-interferon as well as alpha-interferon inhibited induction of immunoglobulin synthesis by Epstein-Barr virus but not by pokeweed mitogen in B lymphocytes from adult but not from newborn humans. The interferons inhibited the infected B lymphocytes directly, irrespective of the Epstein-Barr virus immune status of the donor, and their inhibitory effect was synergistic.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2580994      PMCID： PMC254835     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  27 in total

Review 1.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon.

Authors:  W R Fleischmann; J A Georgiades; L C Osborne; H M Johnson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

3.  Spontaneous interferon production and Epstein-Barr virus antigen expression in human lymphoid cell lines.

Authors:  A Adams; B Lidin; H Strander; K Cantell
Journal:  J Gen Virol       Date:  1975-08       Impact factor: 3.891

4.  Effect of interferon on lymphocyte transformation and nuclear antigen production by Epstein-Barr virus.

Authors:  J Menezes; P Patel; H Dussault; J Joncas; W Leibold
Journal:  Nature       Date:  1976-04-01       Impact factor: 49.962

5.  Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes.

Authors:  L Einhorn; I Ernberg
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

6.  Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations.

Authors:  E Yefenof; T Bakacs; L Einhorn; I Ernberg; G Klein
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

7.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

8.  A monoclonal antibody for large-scale purification of human leukocyte interferon.

Authors:  D S Secher; D C Burke
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

9.  The T cell dependence of B cell differentiation induced by pokeweed mitogen.

Authors:  R G Keightley; M D Cooper; A R Lawton
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

10.  Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.

Authors:  G Miller; M Lipman
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307
View more
  1 in total

1.  Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.

Authors:  Daniel Salamon; Monika Adori; Dorina Ujvari; Liang Wu; Lorand L Kis; Harsha S Madapura; Noemi Nagy; George Klein; Eva Klein
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.